Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Are thresholds for elective surgery too high?
| The first 150 words of the full text of this article appear below. |
In their paper on bmj.com, Roberts and colleagues used record linkage analysis to compare mortality rates after elective colectomy, emergency colectomy, and no colectomy in people admitted with inflammatory bowel disease.1 The results are important and indicate that thresholds for undertaking elective colectomy in clinical practice are too high.
The chronic inflammatory bowel diseases—ulcerative colitis and Crohn's disease—affect 1.4 million people in the United States and 2.2 million people in Europe.2 They result in substantial morbidity, lost days at work, and reduced quality of life. Despite a variety of advances in medical treatment, 20-30% of patients with ulcerative colitis need surgery at some time,3 while the lifetime risk of surgery for Crohn's disease is as high as 80%.4 In people with severe inflammatory bowel disease the long term effectiveness of drugs, such as immunomodulators, rarely exceeds 40%. Surgery can be regarded as a cure for ulcerative colitis, albeit an imperfect
J D Sanderson, consultant gastroenterologist, G C Parkes, clinical research fellow and gastroenterology specialist registrar
Department of Gastroenterology, Guy's and St Thomas's Foundation Trust, London SE1 7EH
jeremy.sanderson@kcl.ac.uk